As each cluster consists of a heterogeneous group of patients, subsequent survival tree analyses within the clusters revealed the different contributions of cancer stage/grade, radiotherapy treatment, TMB, BRAF or KRAS mutation status in predicting the relative risk of death in patients with colorectal cancer. This evidence concerns the gene BRAF and cancer.